Laurion Capital Management LP Horizon Therapeutics Public LTD CO Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $87 Million - $101 Million	902,739 Added 135.54%	1,568,775 $161 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $71.5 Million - $75.6 Million	666,036 New	666,036 $72.7 Million
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $254,866 - $306,056	-2,773 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$86.24 - $95.92 $239,143 - $265,986	2,773 New	2,773 $260,000
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $1.39 Million - $1.85 Million	-19,349 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $1.3 Million - $1.63 Million	19,349 New	19,349 $1.42 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.